GI Dynamics appoints Stephen Linhares as the Vice President for clinical and regulatory affairs. The company is in talks for its project of Endobarrier for patients with type 2 diabetes and obesity. The new appointment is projected to take the project pipeline to the next level with its new deals and strategies. Its focused role with GI dynamics and clinical trial of Endobarrier in India with Apollo sugar will be the center of attention.
